Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-19
2005-07-19
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S266230, C514S303000, C514S312000, C514S364000, C514S387000, C514S397000, C514S400000, C544S012000, C544S284000, C546S118000, C546S157000, C548S144000, C548S305100, C548S305700, C548S310100
Reexamination Certificate
active
06919331
ABSTRACT:
The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
REFERENCES:
patent: 3394141 (1968-07-01), Sparatore
patent: 4324794 (1982-04-01), Tidwell et al.
patent: 5256668 (1993-10-01), Hsu et al.
patent: A-14704 (1998-12-01), None
patent: 058146 (1982-08-01), None
patent: WO 00/04900 (2000-02-01), None
patent: WO 00/38508 (2000-07-01), None
patent: WO 01/00611 (2001-01-01), None
patent: WO 01/00612 (2001-01-01), None
patent: WO 01/00615 (2001-01-01), None
patent: WO 01/36395 (2001-05-01), None
F. Pagani, et al, Boll. Chim. Farm., 104, pp. 427-431, 1965.
G. Paglietti, et al, Il. Farmaco-Ed. Sc., 30, pp. 505-511, 1975.
S. Shigeta, et al, Antiviral Chemistry & Chemotherapy, 3(3), pp. 171-177, 1992.
S. N. Kolodyazhnaya, et al, “Nitrogen-containing bisheterocyclic systems. II. Nature of the influence of the 2-benzimidazolyl radical,” Chemical Abstracts, 72(21), p. 395, col. 1, Abstract No. 111365d, 1970 (Khimiya Geterotsiklicheskikh Soedinenii, pp. 238-244, (2), 1970 (Russ.).
Cianci Christopher
Civiello Rita L.
Combrink Keith
Meanwell Nicholas
Sun Yaxiong
Bristol--Myers Squibb Company
DuBoff Samuel J.
Epperson James
Kifle Bruck
LandOfFree
Substituted 2-methyl-benzimidazole respiratory syncytial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-methyl-benzimidazole respiratory syncytial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-methyl-benzimidazole respiratory syncytial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389206